Cheat sheet
NAPLEX Cheat Sheet
Foundational Knowledge
- 25% of exam
- PK Core Calculations Biostatistics Compounding Evidence
Medication Use Process
- 25% of exam
- Orders Substitution Immunizations Handling Medication Use Picker
Assessment and Treatment
- 40% of exam
- History Therapy Fit Monitoring Counseling Therapy Picker
Professional Practice
- 5% of exam
- Reporting Public Health Ethics Social Drivers
Management and Leadership
- 5% of exam
- Operations Inventory Quality Leadership
Quick Facts
- Exam NAPLEX
- Owner NABP
- Delivery Pearson VUE
- Time 6 hours
- Questions 225 total
- Scored 200 scored
- Pass 75 scaled
- Result Pass/fail
- Attempts 5 total
- Blueprint May 1 2025
PK Triad FO
- Vd, clearance, half-life travel together.
- Vd Cl t1/2 ke
Scored vs Pretest FO
Scored
- 200 items
- Counts toward pass
Pretest
- 25 items
- Not identified
- Treat every item as scored
Calculation Picker FO
- Renal dosing → Cockcroft-Gault ( Use CrCl )
- Weight dose → mg/kg ( Convert kg )
- Manual drip → gtt/min ( Drop factor )
- Infusion pump → mL/hr ( Concentration first )
- Electrolyte amount → mEq ( Valence matters )
- Nutrition calories → TPN math ( Macros separate )
- Chemo dosing → BSA ( Verify caps )
- Mix strengths → Alligation ( Percent check )
PK Core FO
- ADME Drug movement
- Vd Amount over concentration
- Cl Removal efficiency
- t1/2 Concentration halves
- ke Elimination constant
- AUC Total exposure
- Css Steady state
- F Bioavailability fraction
First vs Zero Order FO
First-order
- Constant fraction
- Stable half-life
Zero-order
- Constant amount
- Capacity saturated
- Phenytoin can saturate
Calculations FO
- lb to kg Divide by 2.2
- mg/kg Dose times weight
- mL/hr Volume over hours
- gtt/min mL/hr times factor
- mEq mg times valence/MW
- mOsm Particles per liter
- CrCl Cockcroft-Gault dosing
- BSA Mosteller formula
ARR vs RRR FO
ARR
- Absolute difference
- Needed for NNT
RRR
- Relative reduction
- Can look larger
- NNT uses ARR
Evidence FO
- P value Chance under null
- CI Estimate precision
- ARR Absolute risk difference
- RRR Relative risk drop
- NNT One benefit count
- NNH One harm count
- Bias Systematic error
- Power Detects true effect
Compounding FO
- USP 795 Nonsterile compounding
- USP 797 Sterile compounding
- USP 800 Hazardous drugs
- BUD Beyond-use date
- Aseptic Prevents contamination
- CSP Sterile preparation
- Incompatibility Physical or chemical
- Stability Potency maintained
Five Rights ME
- Patient, drug, dose, route, time.
- Patient Drug Dose Route Time
Contraindication vs Precaution ME
Contraindication
- Do not give
- Risk unacceptable
Precaution
- Assess first
- May delay
- Contraindication blocks therapy
Medication Use Picker ME
- Unclear order → Clarify ( Before dispense )
- Contraindicated drug → Hold ( Contact prescriber )
- Formulary issue → Therapeutic alternative
- Shortage exists → Reserve supply ( Clinical priority )
- Vaccine adverse event → VAERS
- Temperature breach → Quarantine ( Check stability )
Orders ME
- Indication Why drug needed
- Dose Amount per administration
- Route How administered
- Frequency How often
- Duration Treatment length
- Allergy Avoid trigger
- Contraindication Do not use
- Boxed warning Serious risk
Medication Use ME
- Prescribing Therapy ordered
- Transcribing Order documented
- Dispensing Product supplied
- Administering Dose given
- Monitoring Response checked
- Substitution Alternative selected
- Shortage Supply limited
- REMS Risk program
Immunizations ME
- Indication Vaccine recommended
- Contraindication Vaccine avoided
- Precaution Assess risk
- Live vaccine Avoid immunocompromise
- Cold chain Temperature control
- VIS Patient handout
- VAERS Vaccine event report
- ACIP Schedule guidance
Handling ME
- Storage Required conditions
- Excursion Temperature breach
- Quarantine Hold product
- Hazardous Special controls
- Sharps Puncture container
- Disposal Safe removal
- Recall Product removed
- Chain Custody trace
Therapy Problems PA
- Need, fit, dose, safety, adherence.
- Indication Effectiveness Safety Adherence
Interaction vs Duplication PA
Interaction
- Exposure changes
- Toxicity or failure
Duplication
- Same purpose
- Unneeded overlap
- Check both every profile
Therapy Picker PA
- No indication → Stop therapy ( Avoid harm )
- Untreated condition → Add therapy
- Goal unmet → Intensify ( If adherent )
- ADR likely → Switch therapy
- Renal decline → Adjust dose
- Poor adherence → Simplify regimen
History PA
- PMH Disease history
- Med list All therapies
- Allergies Reaction details
- Adherence Actual use
- Pregnancy Fetal risk
- Renal Dose adjustment
- Hepatic Metabolism risk
- Social Care barriers
Efficacy vs Safety PA
Efficacy
- Goal achieved
- Disease controlled
Safety
- Harms acceptable
- Labs stable
- Passing answers balance both
Therapy Fit PA
- Indication Needs therapy
- Efficacy Meets goal
- Safety Harms acceptable
- Duplication Same purpose
- Omission Missing therapy
- Interaction Exposure altered
- ADR Drug harm
- Toxicity Excess exposure
Monitoring PA
- Goal Target outcome
- Endpoint Measured result
- Baseline Starting value
- Follow-up Recheck timing
- Lab Objective measure
- Vitals Clinical signs
- TDM Drug concentration
- Deprescribe Stop safely
High-Yield Therapy PA
- HTN BP goal therapy
- Diabetes A1c plus comorbidities
- HFrEF Four pillars
- AFib Stroke prevention
- ID Site and organism
- Asthma Controller plus reliever
- Psych Efficacy plus safety
- Pain Function and risk
Reporting Split PR
- Vaccines to VAERS; drugs to MedWatch.
- VAERS MedWatch Safety Signal
MedWatch vs VAERS PR
MedWatch
- Drugs/devices
- FDA safety
VAERS
- Vaccines
- Adverse events
- Vaccine event goes VAERS
Practice Safety PR
- MedWatch Drug event report
- VAERS Vaccine event report
- Stewardship Optimize antimicrobials
- Naloxone Opioid reversal
- Cessation Tobacco treatment
- SDOH Access barriers
- Autonomy Patient choice
- Confidentiality Protect privacy
Quality Cycle MA
- Plan, do, study, act.
- Plan Do Study Act
RCA vs PDSA MA
RCA
- Find system causes
- After event
PDSA
- Test improvements
- Iterative cycle
- Analyze then improve
Safety Picker MA
- High-alert drug → Double-check
- Name confusion → Tall man
- System error → RCA
- Process trend → CQI ( PDSA cycle )
- Serious recall → Class I ( Act immediately )
- Inventory mismatch → Cycle count
Operations MA
- ADC Automated dispensing
- BCMA Barcode administration
- CPOE Electronic ordering
- LASA Name confusion
- Tall man Name differentiation
- Double-check Independent verification
- Just culture Systems focus
- High-alert Severe harm risk
Inventory + Quality MA
- Cycle count Rotating inventory count
- Perpetual Real-time inventory
- Class I Serious recall
- Class II Reversible risk
- Class III Unlikely harm
- MUE Medication use review
- RCA System cause analysis
- PDSA Improvement cycle
Common Traps
75 Scaled
- Not 75 percent ≠ Competency threshold
Pass Result
- Numeric score hidden ≠ Fail report detailed
No Backtracking
- No skipped items ≠ No later review
CrCl Dosing
- Cockcroft-Gault ≠ Not eGFR default
Pretest Items
- Mixed into exam ≠ Not marked
Live Vaccines
- Avoid immunocompromise ≠ Inactivated usually safer
High-Alert Drugs
- Not common drugs ≠ Severe harm drugs
Recall Classes
- Class I serious ≠ Class III least harmful
Last Minute
- 1. Domain 3 is 40%
- 2. Use 200 scored weights
- 3. 225 questions, 6 hours
- 4. Each answer locks
- 5. Treat all items scored
- 6. CrCl for renal dosing
- 7. NNT equals one over ARR
- 8. Five rights before administer
- 9. Quarantine temperature excursions
- 10. VAERS for vaccine events
- 11. MedWatch for drug events
- 12. RCA finds system causes
NABP NAPLEX North American Pharmacist Licensure Examination
- Practice Questions 200 questions Study Guide 20 topics Cheat Sheet 120 facts Flashcards 50 cards Videos 3 videos Blogs 3 blogs Free CE Podcast